ask="N/A"
ask_size="N/A"
average_daily_volume="164197"
bid="N/A"
bid_size="N/A"
book_value="7.04"
change="+0.05"
change_from_200_day_moving_average="4.00"
change_from_50_day_moving_average="0.04"
change_from_52_week_high="-3.10"
change_From_52_week_low="8.85"
change_in_percent="+0.24%"
close="21.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.17"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="18634000"
high="21.27"
high_52_weeks="24.30"
last_trade_date="2/16/2017"
last_trade_price="21.20"
last_trade_size="10511"
last_trade_time="4:00pm"
low="20.90"
low_52_weeks="12.35"
market_capitalization="604.52M"
moving_average_200_day="17.20"
moving_average_50_day="21.16"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="36.60"
open="21.25"
pe_ratio="N/A"
peg_ratio="-0.57"
percent_change_from_200_day_moving_average="+23.26%"
percent_change_from_50_day_moving_average="+0.20%"
percent_change_from_52_week_high="-12.76%"
percent_change_from_52_week_low="+71.66%"
previous_close="21.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.00"
price_per_sales="2010.31"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="28.66"
stock_exchange="NGM"
symbol="RVNC"
volume="297508"
weeks_range_52="12.35 - 24.30"
